The representatives of RECETOX participated at second annual meeting of DISCERN project. Prof. Martin Bobak and dr. Elliott J. Price participated physically, while dr. Petra Bořilová-Linhartová, dr. Ondřej Mikeš and dr. Pavel Čupr virtually.
Researchers from the International Agency for Research on Cancer (IARC) are hosting the second annual meeting of the Discovering the Causes of Three Poorly Understood Cancers in Europe (DISCERN) project on 23–24 May 2024 at IARC in Lyon, France.
The meeting brings together representatives of the 19 DISCERN consortium partners to review progress, engage in scientific discussions, and plan for future steps in the project. The meeting also includes a special Renal Cancer Workshop, during which some of the most renowned renal cancer researchers will consider the latest information about the causality, epidemiology, and exposures related to this topic. The workshop is organized in three main sessions: (i) descriptive epidemiology, (ii) molecular data instrumental for discovering ubiquitous exposures, and (iii) reflections on assessing causality.
The aim of the workshop is to define the current scientific understanding of the ubiquity of carcinogens and other exposures associated with renal cancer. In addition, the workshop participants will try to develop methods to better integrate epidemiological approaches and molecular data in research on renal cancer etiology and prevention.
A report summarizing the state of the art, key take-away messages, and future directions is planned, to be published later this year.
source: IARC
In their latest study, scientists from RECETOX (MUNI), the University at Buffalo in the U.S., the National Institute of Public Health in Prague, and University College London in the U.K. found that education plays a role in protecting lung health during the aging process.
From November 5–7, 2024, we participated in the annual meeting of the European consortium ACTRIS. This event serves as a key platform for regular partner meetings, fostering collaboration, sharing the latest updates and experiences, and discussing critical topics related to the development and operation of the ACTRIS research infrastructure.
